Search

everythinglearnresearchcommunity

for

Search:↓

Baldness score can't be used to predict prostate size.

Human prostate cells produce more WISP1/CCN4 when there's not enough oxygen.

Researchers created a simple tool to predict bladder blockage from prostate enlargement using urine flow rate and prostate volume.

Finasteride is a safe and effective long-term treatment for prostate enlargement, reducing prostate volume and related symptoms.

Large prostate patients more likely to have hair loss.

Certain gene variants may raise the risk of prostate enlargement, but taking NSAIDs could reduce this risk.

Using a single PSA level to decide on a prostate biopsy is not effective; a more personalized approach considering various factors is recommended.

Cone beam computed tomography can allow for smaller safety margins around the target area in prostate cancer radiation treatment if used for ongoing treatment checks.

Finasteride doesn't harm male fertility or sperm quality, but may slightly reduce ejaculate volume.

Long-term testosterone therapy can cause hormone suppression, affect prostate and heart health, and alter physical characteristics, but does not increase prostate cancer risk and needs more research for full risk assessment.

Different drugs for prostate-related urinary symptoms work but have various side effects, and treatment should be tailored to the individual.

Early hair loss may indicate prostate issues.

5 alpha-reductase inhibitors can slightly improve symptoms of enlarged prostate but have a high risk of sexual side effects.

Early hair loss may indicate future prostate issues.

Androgen levels can increase at any age, affecting symptoms like acne, hair loss, and prostate size.

Dutasteride effectively treats benign prostatic obstruction, improves urinary flow, reduces prostate size, and may prevent prostate cancer, but can cause sexual side effects.

Stopping finasteride improves sperm quality but not semen volume in young men.

There is no link between hair loss and prostate enlargement.

Early hair loss in men could be a sign of non-cancerous prostate enlargement, and treating hair loss early might help prevent prostate issues later.

Hair loss can be an early sign of prostate enlargement.

People with early-onset hair loss (AGA) have a higher risk of heart disease, metabolic syndrome, and prostate enlargement.

Finasteride helps reduce prostate size and symptoms in BPH but is less effective than terazosin and works best for larger prostates.

Finasteride treats enlarged prostate and baldness, but may cause limited urinary improvement and sex-related side effects.

Certain inhibitors can potentially treat prostate cancer and other hormone-dependent conditions by controlling sex hormone levels in cells.

After prostate removal surgery, higher initial prostate size was linked to higher urethral PSA levels and more severe male pattern baldness.

Finasteride slightly improves prostate symptoms but has minimal difference from placebo.

A young dog with an enlarged prostate and cysts improved significantly after treatment and surgery.

Dutasteride effectively treats enlarged prostate, reduces prostate cancer risk, and promotes hair regrowth with few side effects.

Finasteride reduces prostate size and serum levels, helping manage benign prostatic hyperplasia, without affecting prostate cancer detection. Regular monitoring is needed for users.

Finasteride effectively treats hair loss and enlarged prostate in men, with mild side effects.